Nuojiang Shengming Keji
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nuojiang Shengming Keji - overview
Established
2022
Location
Jinan, Shandong, China
Primary Industry
Healthcare IT
About
Based in Jinan, China and founded in 2022, Nobel Prize Life Science (Shandong) Co. , Ltd. , trading as Nuojiang Shengming Keji, focuses on integrating international scientific research with AI medical technology to provide precision healthcare solutions. In March 2026, Nuojiang Shengming Keji raised CNY 17.
5 million in Angel funding from Zhongye Zhengqi (Beijing) International Investment Co. , Ltd. The company provides an innovative digital ecosystem that includes AI-driven sub-health clinical research, "smart robot doctors," and a closed-loop service model combining Nobel Prize-winning achievements with grassroots medical empowerment. The company generates revenue by commercializing its AI medical systems and providing specialized health management services.
The Angel funding raised in March 2026 will be mainly used for the technological iteration of AI medical systems, the commercialization of Nobel Prize-winning achievements, talent team building, and the promotion of grassroots applications.
Primary Industry
Healthcare IT
Sub Industries
Healthcare, Healthcare IT
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.